R&F Capital Advisors’s Labcorp LH Stock Holding History

R&F Capital Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,827	Closed	-$532K	–	762
2016 Q4	$532K	Buy	+4,827	New	+$536K	0.19%	166

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

R&F Capital Advisors's LH Position: Q1 2017 in Review

R&F Capital Advisors sold out of Labcorp (LH) in Q1 2017, closing a stake of 4,827 shares — an estimated $532K sold.

R&F Capital Advisors first reported a position in LH in Q4 2016 and held it in 1 quarter. The position peaked at $532K in Q4 2016. 693 funds tracked by Wall St. Rank hold LH as of Q1 2017.

R&F Capital Advisors reported no remaining Labcorp position as of Q1 2017 after selling out during the quarter.
R&F Capital Advisors sold 4,827 Labcorp shares in Q1 2017, an estimated $532K.
R&F Capital Advisors first reported a position in Labcorp in Q4 2016 and held it in 1 quarter.
R&F Capital Advisors's Labcorp position peaked at $532K in Q4 2016.
693 funds tracked by Wall St. Rank held Labcorp as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.